News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Protox Therapeutics Inc. (PRX.V) Reports Positive Phase2 Trial Results For Urological Drug


1/13/2010 9:52:41 AM

(RTTNews) - Monday, Protox Therapeutics, Inc. (PRX.TO: News ) announced positive top-line results for its phase2b trial of PRX302 or TRIUMPH in patients with the urological condition benign prostatic hyperplasia or BPH.

Read at RTT News

comments powered by Disqus
RTT News
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES